EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 111 filers reported holding EPIZYME INC in Q2 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,810,000 | +51.5% | 207,760 | +179.3% | 0.01% | 0.0% |
| Q2 2020 | $1,195,000 | +101.5% | 74,397 | +94.6% | 0.01% | +33.3% |
| Q1 2020 | $593,000 | -87.5% | 38,239 | -90.0% | 0.01% | -72.7% |
| Q1 2019 | $4,752,000 | +32.6% | 383,348 | -34.1% | 0.02% | -40.5% |
| Q4 2018 | $3,585,000 | -46.8% | 582,103 | -8.5% | 0.04% | +27.6% |
| Q3 2018 | $6,742,000 | +487.3% | 636,102 | +883.9% | 0.03% | -39.6% |
| Q1 2018 | $1,148,000 | -33.3% | 64,651 | -51.6% | 0.05% | +128.6% |
| Q3 2015 | $1,720,000 | +43.5% | 133,714 | +167.5% | 0.02% | +31.2% |
| Q2 2015 | $1,199,000 | +79.2% | 49,979 | +40.1% | 0.02% | +77.8% |
| Q1 2015 | $669,000 | -5.2% | 35,665 | +36.9% | 0.01% | -10.0% |
| Q3 2014 | $706,000 | +167.4% | 26,059 | +207.2% | 0.01% | +150.0% |
| Q2 2014 | $264,000 | – | 8,482 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |